Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-04-11

Clinical Trial Update: The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating perioperative pregabalin to prevent chronic post-thoracotomy pain syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Queen's University | Conditions: Chronic Pain | Phase 3 | Status: WITHDRAWN